DEFYMED
Desconocido
iNanoBIT: Integration of Nano and Biotechnology for beta cell and islet Transplantation
DEFYMED SAS
participó en un
H2020:
H2020-NMBP-2016-2017
The iNanoBIT project is aimed to apply nanotechnologies for imaging porcine pancreatic islet cellular transplants and induced pluripotent st...
2017-10-16 - 2023-03-31 | Financiado
2017-10-16 - 2023-03-31 | Financiado
BIOSID: A bioartificial pancreas to treat type 1 diabetes optimization of cell survival and function in pre...
DEFYMED SAS
participó en un
FP7:
MAILPAN (MAcroencapsulation of PANcreatic Islets) is a prototype of bioartificial pancreas usable in the human designed to treat type 1 diab...
Financiado
Financiado
* No se disponen de datos de la empresa actual.